DNAPrint Genomics Inc DNAG:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 02/28/24 EDT
0.00UNCH (UNCH)
52 week range
0.00 - 0.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date11/09/23
  • 52 Week Low0.00
  • 52 Week Low Date02/28/24

Key Stats

  • Market Cap644.61
  • Shares Out644.61M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta7.40
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date11/09/23
  • 52 Week Low0.00
  • 52 Week Low Date02/28/24
  • Market Cap644.61
  • Shares Out644.61M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta7.40
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-5.785M
  • ROE (TTM)-
  • Revenue (TTM)1.932M
  • Gross Margin (TTM)23.14%
  • Net Margin (TTM)-235.40%
  • Debt To Equity (MRQ)-66.09%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On DNAPrint Genomics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
DNAPrint genomics, Inc. is a development-stage pharmaceutical company. As of March 15, 2007, the Company’s pharmacogenomics products were still in development. The Company generates revenues in its consumer, forensic and genotyping services, but these services have not resulted in the generation of significant revenues. During the year ended December 31, 2006, the Company’s revenues were from the sales of its ancestry product, AncestryByDNA and genotyping services. The...
Hector Gomez M.D., Ph.D.
Chairman of the Board, Chief Medical Officer
Karen Surplus
Chief Accounting Officer
Address
505 Paradise Rd Ste#281
Swampscott, MA
01907
United States

Top Peers

SYMBOLLASTCHG%CHG
ENSC
Ensysce Biosciences Inc
0.5802-0.0496-7.8755%
GMDAQ
Gamida Cell Ltd
0.0166+0.001+6.4103%
EPRSQ
EPIRUS Biopharmaceuticals Inc
0.00UNCHUNCH
INBS
Intelligent Bio Solutions Inc
2.80+0.12+4.48%
ARDS
Aridis Pharmaceuticals Inc
0.0615-0.0045-6.7803%